Cargando…
Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2
[Image: see text] The outbreak caused by SARS-CoV-2 has taken many lives worldwide. Although vaccination has started, the development of drugs to either alleviate or abolish symptoms of COVID-19 is still necessary. Here, four synthetic peptides were assayed regarding their ability to protect Vero E6...
Autores principales: | Souza, Pedro F.N., vanTilburg, Maurício F., Mesquita, Felipe P., Amaral, Jackson L., Lima, Luina B., Montenegro, Raquel C., Lopes, Francisco E.S., Martins, Rafael X., Vieira, Leonardo, Farias, Davi F., Monteiro-Moreira, Ana C. O., Freitas, Cleverson D.T., Bezerra, Arnaldo S., Guedes, Maria I. F., Castelo-Branco, Débora S.C.M., Oliveira, Jose T.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063117/ https://www.ncbi.nlm.nih.gov/pubmed/35530749 http://dx.doi.org/10.1021/acsomega.2c02203 |
Ejemplares similares
-
A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor
por: Souza, Pedro F.N., et al.
Publicado: (2020) -
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
por: Souza, Pedro F.N., et al.
Publicado: (2022) -
The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play
por: Souza, Pedro F.N., et al.
Publicado: (2021) -
New Insights into the Mechanism of Antibacterial Action of Synthetic Peptide Mo-CBP(3)-PepI against Klebsiella pneumoniae
por: Branco, Levi A. C., et al.
Publicado: (2022) -
Synergistic Antibiofilm Activity between Synthetic Peptides and Ciprofloxacin against Staphylococcus aureus
por: Neto, Nilton A. S., et al.
Publicado: (2022)